Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Invertebrate gamma-aminobutyric acid (GABA)-gated chloride receptors are pentameric ligand-gated ion channels that mediate fast inhibitory neurotransmission in the nervous systems of insects, arachnids, and nematodes [1, 2]. These receptors are members of the Cys-loop superfamily and function by opening a chloride-selective pore upon binding the neurotransmitter GABA, leading to membrane hyperpolarization and the suppression of neuronal activity [1, 3]. They are critical for regulating motor coordination, sensory processing, and behavior in invertebrates [2]. Due to their essential role and structural differences from vertebrate GABA-A receptors, they serve as primary targets for numerous insecticides and parasiticides, including phenylpyrazoles (e.g., fipronil), cyclodienes (e.g., dieldrin), and isoxazolines (e.g., fluralaner) [2, 4]. These compounds typically act as non-competitive antagonists that bind within the channel pore to block ion flow, leading to overexcitation of the nervous system and death of the organism [4, 5]. However, the development of resistance, often mediated by mutations in the Rdl (resistance to dieldrin) gene, and potential cross-reactivity with mammalian GABA receptors present significant therapeutic and environmental challenges [1, 5].
Non-competitive antagonism of the chloride channel pore, which blocks the inhibitory effect of GABA and leads to lethal neuronal overstimulation [2, 4, 5].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate gamma-aminobutyric acid-gated chloride receptor (iGABACl).